AzTrials
AzTrials

Endodontically Treated TeethNCT03298152

One Year Clinical Evaluation of E-max CAD Versus Cerasmart Endocrowns in Anterior Endodontically Treated Teeth

A study testing CERASMART Endocrown and Emax Endocrown in people with Endodontically Treated Teeth, run by Cairo University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Nowadays Endocrowns are classified as conservative treatment modality for restoration of Endodontically treated teeth in which pulp chamber is used as a retentive resource. With the advancement in technology in the field of adhesive dentistry its use is increasing day by day in clinical practice. Read more about this study

Who is it for?
Ages 20 to 60 years
Conditions the study is for
Endodontically Treated Teeth
What is being tested?
CERASMART Endocrown and Emax Endocrown
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 siteEgypt
Study dates
Dec 2017to Apr 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • 1. Age range of the patients from 20-60 years old who can read and sign informed consent document.
  • 2. Medically free patients or with controlled systemic disease. 3. No active periodontal disease.

Who cannot join

  • 1. Patients under 20 years old. 2. Patients with bad oral hygiene and motivation. 3. Patients with psychiatric problems or unrealistic expectation (patient have phobia from dental treatments or needle bricks).
  • 4. Patients with parafunctional habits (clencing/bruxism).

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Dentistry

    Cairo

Other trials in Egypt

About this study

Official title: One Year Clinical Evaluation of E-max CAD Versus Cerasmart Endocrowns in Anterior Endodontically Treated Teeth:A Randomized Clinical Trial

Nowadays Endocrowns are classified as conservative treatment modality for restoration of Endodontically treated teeth in which pulp chamber is used as a retentive resource.

With the advancement in technology in the field of adhesive dentistry its use is increasing day by day in clinical practice. Acid Etchable ceramics such as lithium Disilicate based ceramics are the gold standard ceramic material used for Endocrowns. The Etchable property and the translucent character of lithium Disilicate enhance strength and esthetic property.

Read more

A new material CERASMART (Force Absorbing Flexible nano ceramic CAD/CAM block) contain high density of ultrafine glass particles with 71 wt% filled nano-composite. It combines high strength and unique aesthetics. full homogeneous and even distribution of nano ceramic network lead to unique physical properties for cerasmart . Uniform scuttle (very short inter-particle distance) of silanated and bonded particles is key to delivering CERASMART's™ with high strength and acceptable level of marginal adaptation.

So, it can perfectly use in posterior, anterior, inlay, onlay, and implant restorations and also enables minimum tooth reduction for more conservative restoration.

Awad et al (1) found that Cerasmart showed significantly higher flexural strength and modulus of elasticity, with lower flexural modulus values compared to other groups. Also, result in smoother margins compared with other types of ceramic.

So, present research will evaluate patient satisfaction, bonding properties and marginal adaptation

Read the detailed description

This study will carried out on patients collected from the dental clinics in fixed prosthodontics clinic, Faculty of Dentistry, Cairo University

the visits will be designed as follows:

.1st visit: (N.N) will call participants before tooth preparation procedure for X-ray reviewing and pre-operative photographing using a Professional digital camera also; Impression will be taken using the alginate impression material * for study cast analysis with suitable stock tray** size.

Each participant will be asked to sign consent form written in patient native language.

2nd visit: (Tooth preparation) After performing adequate disinfection and sterilization process for each instrument and tools will be used in this trial; the anesthetic solution (Anesthetic solution: Septanest SP, 4%, Septodont, France.) will be injected using infiltration technique. Then patients will be left from five to ten minutes then; the operator will check with the subjective for anasthesia.

Full preparation will be carried out following the principles of Endocrown preparation with deep chamfer finish line while 2 observers will select visually the appropriate shade. Final vinylpolysiloxane impressions will be taken for each participant in each groupusing the suitable tray size.

After final setting impressions will be checked for accuracy using magnifying loops (Magnifying loop: Univet optical technologies, Italy).

Then protemp temporary endocrowns ) Temporary crown material: Structure, Voco, GMBH, Germany.( will be cemented using eugenol free (Temporary cement: RelyX Temp, USA).

Impressions will be sent to the lab, poured with extra hard stone material. Then it will be removed from the impression after complete setting.

Endorowns for each patient will be fabricated using either lithium di-silicate material (Emax) or Cerasmart blocks according to the random allocation of the patients

3rd visit: Participants will be called again for final cementation. Temporary crown will be removed and abutments will be cleaned of any residues using pumice slurry ) Pumice slurry: DCL, Dental composite LTD, England.( applied with bristle brush and rubber cup under water irrigation.

Proper isolation will be done before cementation then permanent dual cure resin cement (Permanent cement: Bifix-QM, Voco Gmbh, Germany ) will be used for luting of permanent crowns according to manufacturer instructions. Ask the patients to hold the crown under occlusal compression until luting cement polymerization. 5 minutes later, excess cement will be removed.

Measuring of different outcomes will start in this visit for all patients.

The following assessment surveys (clinical evaluations) will done for both groups:

All patients will be recalled after 3, 6, 9, and 12 months. For each recall examination, evaluator will performed the direct clinical evaluation using modified USPHS criteria for margin integrity and gross fracture.

Visual inspection will be used for gross fracture evaluation. Endorowns that intact and fully retained will be rated 'Alfa', Endocrowns with partially retained with some portion of the restoration still intact will be rated as 'Bravo'and endocrowns completely missing will be rated as 'Charlie'.

Visual inspection and explorer will be using for marginal integrity evaluation. Endocrowns with no catch with The explorer and no visible crevice along the periphery of the restoration will be rated as Alpha (A), Endocrowns with explorer catches with visible evidence of a crevice, with and/or the base is not exposed, and the restoration is not mobile will be rated as Bravo (B) and endocrowms with explorer penetrates and extended to the dento-enamel junction will be rated as Charlie ©.

In addition, questionnaires will be used to evaluate patients' satisfaction and potential postoperative discomfort as the following questions:

  1. Are you satisfied with your endocrown appearance?
  2. Are you satisfied with your endocrown shade?
  3. Do you feel your endocrown are poorly aligned?
  4. Do you feel your endocrown are protruding?
  5. Are you hiding your teeth while smiling?

Adherence improvement session will be taking place in the initial visit. This session will include:

  • Each patient will be informed about the study steps and maintain oral hygiene. Subsequent sessions will occur at the follow-up visits.
  • The patients will be trained for tooth brushing, flossing and instructed all oral hygiene methods after each meal.
  • Instruct the patients to record any abnormalities or mobility in endocrowns.
  • Recall appointment will be performed every two months for aduration of one year to stress on oral hygiene.
  • Data collection methods:

Prosthodontic colleague will assess the outcome of each group. Data will be collected on excel sheets. All categorical data will be presented as risk ratios, while numerical data will be presented by mean and standard deviation. All data will be reported at a confidence interval of 95% and a p value of 5%.

Each factor will be measured as explained in the outcome table. - Outcome results will be written down on the patients' folders by (NN), then will be given to (JG) for data management. All the information will be transferred on excel sheets and saved on a computer in safe place and locked with a password only known to JG. A copy of the data will be saved on a flash drive with JG to provide a back up for the data.

Plans to increase participant retention \& complete follow-up:

Telephone numbers of each patients and address will be taken and included in study, then phone calls and messages will be sent to remind patients before each appointment.

Data management:

JG will enter all data electronically. Patient files are to stored in numerical order in a secured place. J.G and A.Z will have access to data

Data Monitoring:

AZ will be responsible of data monitoring if any lost or delete occurs, in that case: back up data will be taken from (J.G) to provide hard copy for the requested data and A.Z will make final decision.

Harms:

If 50% of the patients showed any unfavorable signs as sever pain, irreparable fracture or shade changes which might affect the results. Then the treatment will be considered as stopped guidelines which necessitate stopping the treatment and interim analysis will be performed.

Auditing:

Auditing of the study design will be done by (AZ).

Ethics and dissemination Research ethics approval Protocol and informed consent form will be reviewed by the Ethics Committee of Scientific Research - faculty of Dentistry - Cairo University.

Protocol amendments:

Any changes in protocol affect the conduct of the study, benefit for patient or patient safety, including changes in study objectives, study design, sample size, study procedures, or significant administrative aspect will require formal amendment to the protocol. Such amendment will be agreed upon by the Council of Department of fixed prosthodontics, Faculty of Dentistry, Cairo University.

Consent:

Researcher will discuss the trial with all patients. Then patient can have an informed discussion with the researcher. Researcher will obtain written consent from patients willing to participate in the trial. All consent forms will write in Arabic language (Appendix 1.1).

Confidentiality:

All information related to study will store securely. All participants' information will store in locked cabinets in areas with limited access. To maintain participant confidentiality all data collection, process, and administrative forms will identify only by a coded ID number. All information related to patient names or other personal identifiers will store separately identified by code number. All local databases will be secured with password-protected access systems.

Access to data:

The investigator and supervisors will give access to the data sets. All data sets will be protected by password. To ensure confidentiality, Participant study information will become confidentially.

Ancillary and post-trial care:

All patients will be followed up 2 years even after the trial ends then might be used for further cohort study.

Dissemination policy:

  • Study results will be published as partial fulfillment the Requirements for PHD degree in fixed prosthodontics.
Being tested
CERASMART Endocrown, Emax Endocrown
Keywords
lithium disilicate endocrowns, cerasmart endocrowns
Medical subject headings
Tooth, Nonvital

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CERASMART EndocrownProcedure or surgery

    Endocrown fixed restoration used to restore endodontically treated anterior teeth using CERASMART blocks

  • Emax EndocrownProcedure or surgery

    Endocrown fixed restoration used to restore endodontically treated anterior teeth using Emax material

Study groups in NCT03298152
Study groupRoleWhat they receive
Emax CAD EndocrownsActive comparatorUsing lithium disilicate e.max restorations is documented in literature as a successful restoration. Two different ceramic crowns systems were investigated clinically for three-years and howed that patient was satisfied with the final restoration
Receives: Procedure: Emax Endocrown
Cerasmart EndocrownsExperimentalA new material CERASMART (Force Absorbing Flexible nano ceramic CAD/CAM block) with high density of ultrafine glass particles with 71 wt% filled nano-composite. It combines high strength and unique aesthetics. full homogeneous and even distribution nano ceramic network lead to unique physical properties for cerasmart . Uniform scuttle (very short inter-particle distance) of silanated and bonded particles is key to delivering CERASMART's™ with exceptional strength, retention, acceptable level of marginal adaptation
Receives: Procedure: CERASMART Endocrown

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gross Fracture

    Categorical Alpha (A): Restoration is intact and fully retained.

    Bravo (B): Restoration is partially retained with some parts of the restoration still intact.

    Charlie (C): Restoration is completely missing

    Measured: one year

Secondary outcomes (2)
  1. Patient satisfaction

    score by Visual Analogue Scale (VAS)

    Measured: one year

  2. Marginal Integrity

    Categorical Alpha (A): The explorer does not catch and no visible crevice along the periphery of the restoration.

    Bravo (B): The explorer catches and with visible evidence of a crevice, which the explorer penetrates, indicating that the edge of the restoration does not adapt closely to the tooth structure. Both dentin and/or the base is not exposed, and no mobility in the restoration.

    Charlie ©: The explorer penetrates and extended to the dento-enamel junction.

    Measured: one year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Oct 2017
  2. Study startDec 2017 (estimated)
  3. Primary completionFeb 2018 (estimated)
  4. Study completionApr 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
32 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03298152
Sponsor's protocol ID
CEBD-CU-2017-09-29
Status last verified
Oct 2017
First submitted
27 Sep 2017
Last updated
12 Oct 2017
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing CERASMART Endocrown and Emax Endocrown in people with Endodontically Treated Teeth, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Oct 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Norhan Abd El Haliem, MDs (002 ext. 01007105072, norhan.naief@dentistry.cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gross Fracture (time frame: one year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Oct 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in